<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOG</journal-id><journal-title-group><journal-title>Open Journal of Obstetrics and Gynecology</journal-title></journal-title-group><issn pub-type="epub">2160-8792</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojog.2021.115059</article-id><article-id pub-id-type="publisher-id">OJOG-109392</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Magnesium Sulfate Effect on Fetal Umbilical Artery and Middle Cerebral Artery Doppler Indicies in Women with Severe Preeclampsia and Eclampsia
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nermeen</surname><given-names>Mohamed Hefila</given-names></name><xref ref-type="aff" rid="aff1"><sub>1</sub></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Obstetrics and Gynecology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt</addr-line></aff><pub-date pub-type="epub"><day>08</day><month>05</month><year>2021</year></pub-date><volume>11</volume><issue>05</issue><fpage>636</fpage><lpage>645</lpage><history><date date-type="received"><day>2,</day>	<month>May</month>	<year>2021</year></date><date date-type="rev-recd"><day>24,</day>	<month>May</month>	<year>2021</year>	</date><date date-type="accepted"><day>27,</day>	<month>May</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objective: 
  To study
   
  MgSO<sub>4</sub> effect
   
  on fetal MCA and UA blood flow changes
   
  using Doppler ultrasound
   
  in cases of severe PET and eclampsia. <b>Materials and Methods: </b>A total of 40 patients with severe PET admitted to El-Shatby Maternity University Hospital, Alexandria (Egypt) were examined before and after administration of MgSO<sub>4</sub> using Doppler study to measure fetal MCA
   
  and UA blood flow changes. <b>Results: </b>After administration
   
  of MgSO<sub>4</sub>, the mean
   
  RI of UA, PI of UA showed a statistically significant decrease (P &lt; 0.001) also the systolic-diastolic ratio (p = 0.001). Mean resistivity index (RI) cerebral showed a statistically significant increasing (P = 0.001), pulsatility index (PI)-cerebral and the systolic-diastolic ratio showed a statistically significant increasing (P &lt; 0.001).
   
  The
   
  C/U (cerebroumblical) ratio increased after the treatment (P &lt; 0.001). <b>Conclusions: </b>Infusion of MgSO<sub>4</sub> significantly decreases the fetal RI, PI, SDR umbilical and increases the fetal RI, PI, SDR MCA and increases cerebroumblical ratio indices obtained by Doppler
   
  examinations.
 
</p></abstract><kwd-group><kwd>Doppler Ultrasound</kwd><kwd> Eclampsia</kwd><kwd> Magnesium Sulfate</kwd><kwd> Preeclampsia</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Preeclampsia is diagnosed when the systolic blood pressure is ≥140 mmHg or diastolic blood pressure is ≥90 mmHg associated proteinuria ≥ 300 mg in 24 hour urine and diagnosed 20 weeks of gestation and it is usually recognized as a systemic disorder resolving with delivery or soon thereafter [<xref ref-type="bibr" rid="scirp.109392-ref1">1</xref>].</p><p>PET and eclampsia are among the most important diseases of pregnancy causing maternal morbidity and mortality associated with high vascular resistance due to vascular spasm with impaired placental blood flow [<xref ref-type="bibr" rid="scirp.109392-ref2">2</xref>].</p><p>Preeclampsia complicates 3% - 5% of all pregnancies, but approximately 7% of those in nulliparas, it remains a major disease causing of maternal morbidity and mortality [<xref ref-type="bibr" rid="scirp.109392-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref5">5</xref>].</p><p>This disease can cause many fetal and maternal complications [<xref ref-type="bibr" rid="scirp.109392-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref9">9</xref>].</p><p>MgSO<sub>4</sub> is the best drug used in treatment of severe PET and eclampsia and prevent maternal and fetal complications [<xref ref-type="bibr" rid="scirp.109392-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref11">11</xref>]. Effect of MgSO<sub>4</sub> on the brain vascular blood flow is still unclear as it may reduce the vasospasm [<xref ref-type="bibr" rid="scirp.109392-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref15">15</xref>].</p><p>The MgSO<sub>4</sub> changes vascular permeability and reduces the edema [<xref ref-type="bibr" rid="scirp.109392-ref10">10</xref>]. It seems to have no adverse effects on the fetus [<xref ref-type="bibr" rid="scirp.109392-ref16">16</xref>], but in response to MgSO<sub>4</sub> injection, fetal brain perfusion may be also altered [<xref ref-type="bibr" rid="scirp.109392-ref17">17</xref>].</p><p>Doppler ultrasound is the best mood to study the mechanisms by which PET affects the fetal circulation [<xref ref-type="bibr" rid="scirp.109392-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref19">19</xref>]. Arterial changes evaluated with Doppler ultrasound can show how the fetus is heamodynamically adapted the changes in PET [<xref ref-type="bibr" rid="scirp.109392-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref21">21</xref>].</p><p>Increase in UA PI is associated with decreased fetal perfusion. If the situation continues, MCA RI will decrease [<xref ref-type="bibr" rid="scirp.109392-ref22">22</xref>].</p><p>In PET, usually we measure the UA doppler changes but recent studies showed that measuring also MCA Doppler changes is adding more beneficial information about fetal wellbeing state [<xref ref-type="bibr" rid="scirp.109392-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref25">25</xref>]. With using the C/U ratio (cerebroumblical ratio) is superior in detecting fetal circulation changes and so prognosis [<xref ref-type="bibr" rid="scirp.109392-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref28">28</xref>]. MgSO<sub>4</sub> effect on the fetal adaptive changes in PET is one of the most important research issues [<xref ref-type="bibr" rid="scirp.109392-ref29">29</xref>].</p><p>Aim of the Work: To study MgSO<sub>4</sub> effect on fetal MCA and UA blood flow changes using Doppler ultrasound in cases of severe PET and eclampsia.</p></sec><sec id="s2"><title>2. Material and Methods</title><p>In this study, all the participants were evaluated before and after MgSO<sub>4</sub> administration. This study was approved by the ethics committee of the Faculty of Medicine University of Alexandria.</p><p>Pregnant cases with sever PET and eclamptic fits who attended to El-Shatby Maternity University Hospital during the period between December 2019 and December 2020 were involved in the study. Inclusion criteria were: Age in the range of 18 - 40 years, Singleton pregnancy, Any gravidity or parity, Gestational age equal to or above 28 weeks, Systolic blood pressure ≥ 160 mmHg or diastolic pressure ≥ 110 mmHg on two occasion six hours or more apart on bed rest, Preeclampsia with new onset grand seizures [<xref ref-type="bibr" rid="scirp.109392-ref30">30</xref>], Spontaneous pregnancy and One or more of the following [<xref ref-type="bibr" rid="scirp.109392-ref30">30</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref33">33</xref>]: (Proteinuria of 24 hour urine of at least 5 g of protein or 3+ or more on two random samples collected four or more hours apart, Sudden oliguria. Central nervous system disturbances, Pulmonary edema or cyanosis, Epigastric or right upper quadrant pain, Liver dysfunction (increase serum levels of SGOT and SGPT), Thrombocytopenia &lt; 100,000/cmm, Fetal growth restriction calculated by Hadlock formula [<xref ref-type="bibr" rid="scirp.109392-ref34">34</xref>]. Exclusion Criteria were: Cases with other systemic disease (e.g., diabetes, hypertension, and autoimmune disorders), multiple pregnancy, Fetuses with congenital anomaly, History of taking opium, smoking and twin pregnancy.</p><p>The goal of the study and the method were described to all patients and written consent form was taken prior to the initiation of study.</p><p>After admission of the patient, the following was done:</p><p>1) Complete history taking.</p><p>2) General and local examination.</p><p>3) Color Doppler ultrasound of fetal UA and MCA, the cerebro-umbilical ratio (middle cerebral artery resistance index/umbilical artery resistance index), pulsatility index (PI) and S/D ratio will were evaluated.</p><p>4) After initial assessment, the obstetrician gives the loading and maintenance dose of MgSO<sub>4</sub>. The loading dose has 4 g of MgSO<sub>4</sub> in 250 ml saline intravenously infusion for 20 min and then the maintenance dose which has 8 g MgSO<sub>4</sub> in 500 ml saline/8 hours.</p><p>Then again MCA and UA Doppler evaluation was done to evaluate blood flow changes.</p><p>Outcome</p><p>This result was compared with APGAR Score of the baby and the out-come of the mother.</p></sec><sec id="s3"><title>3. Results</title><p>1) Umbilical artery Doppler indices</p><p>There were statistical significant differences between umbilical artery PI, RI and cerebroplacental ratio with administration of MgSO<sub>4</sub> (p &lt; 0.001); as shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>2) Middle cerebral artery [MCA] Doppler indices</p><p>There were statistical significant differences between MCA them (p &lt; 0.001); as shown in <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>3) Relation between ultrasonographic assessment of amount of liquor and cerebro-placental ratio (C/U) before and after mgSO<sub>4</sub> administration</p><p>The Cerebro-placental ratio(C/U ratio) before and after mgSO<sub>4</sub> has statistical significant differences in both groups (p = 0.009) and (p = 0.004) with no statistical significant differences between both of them (p = 0.211); as shown in <xref ref-type="table" rid="table3">Table 3</xref>.</p><p>4) Relation between estimated fetal weight (gm) and cerebro-placental ratio (C/U) before and after mgSO<sub>4</sub> administration</p><p>There were 28 cases of normal fetal biometry and 12 case of intrauterine growth restriction. As shown in <xref ref-type="table" rid="table4">Table 4</xref>.</p><p>The Cerebro-placental ratio (C/U ratio) before and after mgSO<sub>4</sub> has statistical</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Comparison between umbilical artery ultrasonographic Doppler evaluation before and after MgSO<sub>4</sub> administration (n = 40)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Umbilical artery</th><th align="center" valign="middle" >Before</th><th align="center" valign="middle" >After</th><th align="center" valign="middle" >p</th></tr></thead><tr><td align="center" valign="middle" >RI (resistance index)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Min. - Max.</td><td align="center" valign="middle" >0.46 - 1.0</td><td align="center" valign="middle" >0.4 - 0.90</td><td align="center" valign="middle"  rowspan="3"  >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >Mean &#177; SD.</td><td align="center" valign="middle" >0.69 &#177; 0.15</td><td align="center" valign="middle" >0.63 &#177; 0.12</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >0.66</td><td align="center" valign="middle" >0.62</td></tr><tr><td align="center" valign="middle" >PI (pulsatility index)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Min. - Max.</td><td align="center" valign="middle" >0.6 - 2.16</td><td align="center" valign="middle" >0.40 - 2.0</td><td align="center" valign="middle"  rowspan="3"  >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >Mean &#177; SD.</td><td align="center" valign="middle" >1.16 &#177; 0.43</td><td align="center" valign="middle" >1.05 &#177; 0.41</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >1.08</td><td align="center" valign="middle" >1.0</td></tr><tr><td align="center" valign="middle" >SDR (Systolic-diastolic ratio)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Min. - Max.</td><td align="center" valign="middle" >0.7 - 7.80</td><td align="center" valign="middle" >0.8 - 6.33</td><td align="center" valign="middle"  rowspan="3"  >&lt; 0.001*</td></tr><tr><td align="center" valign="middle" >Mean &#177; SD.</td><td align="center" valign="middle" >3.30 &#177; 1.37</td><td align="center" valign="middle" >3.03 &#177; 1.11</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >2.90</td><td align="center" valign="middle" >2.69</td></tr></tbody></table></table-wrap><p>p: p value for Paired t-test or Wilcoxon signed ranks test for comparing between before and after; *: Statistically significant at p ≤ 0.05.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparison between middle cerebral artery ultrasonographic Doppler evaluation before and after MgSO<sub>4</sub> administration (n = 40)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Umbilical artery</th><th align="center" valign="middle" >Before</th><th align="center" valign="middle" >After</th><th align="center" valign="middle" >p</th></tr></thead><tr><td align="center" valign="middle" >RI (resistance index)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Min. - Max.</td><td align="center" valign="middle" >0.06 - 0.98</td><td align="center" valign="middle" >0.07 - 0.90</td><td align="center" valign="middle"  rowspan="3"  >tp = 0.001*</td></tr><tr><td align="center" valign="middle" >Mean &#177; SD.</td><td align="center" valign="middle" >0.70 &#177; 0.15</td><td align="center" valign="middle" >0.75 &#177; 0.14</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >0.73</td><td align="center" valign="middle" >0.78</td></tr><tr><td align="center" valign="middle" >PI (pulsatility index)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Min. - Max.</td><td align="center" valign="middle" >0.1 - 2.60</td><td align="center" valign="middle" >0.14 - 2.70</td><td align="center" valign="middle"  rowspan="3"  >Wxp &lt; 0.001*</td></tr><tr><td align="center" valign="middle" >Mean &#177; SD.</td><td align="center" valign="middle" >1.35 &#177; 0.49</td><td align="center" valign="middle" >1.47 &#177; 0.46</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >1.29</td><td align="center" valign="middle" >1.44</td></tr><tr><td align="center" valign="middle" >SDR (Systolic-diastolic ratio)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Min. - Max.</td><td align="center" valign="middle" >0.80 - 10.60</td><td align="center" valign="middle" >1.0 - 11.0</td><td align="center" valign="middle"  rowspan="3"  >Wxp &lt; 0.001*</td></tr><tr><td align="center" valign="middle" >Mean &#177; SD.</td><td align="center" valign="middle" >4.0 &#177; 1.86</td><td align="center" valign="middle" >4.31 &#177; 1.83</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >3.61</td><td align="center" valign="middle" >3.95</td></tr></tbody></table></table-wrap><p>p: p value for Paired t-test or Wilcoxon signed ranks test for comparing between before and after; *: Statistically significant at p ≤ 0.05.</p><p>significant differences in both groups (p = 0.013) and (p = 0.008) with no statistical significant differences between both of them (p = 0.250). As shown in <xref ref-type="table" rid="table4">Table 4</xref>.</p><p>Maternal outcome</p><p>There were no cases of maternal deaths and all cases recovered well.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Relation between ultrasonographic assessment of amount of liquor and cerebro-placental ratio (C/U) before and after MgSO<sub>4</sub> administration</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >C/U ratio</th><th align="center" valign="middle"  colspan="2"  >Liquor</th><th align="center" valign="middle"  rowspan="2"  >T</th><th align="center" valign="middle"  rowspan="2"  >p</th></tr></thead><tr><td align="center" valign="middle" >Normal (n = 32)</td><td align="center" valign="middle" >Oligohydramnios (n = 8)</td></tr><tr><td align="center" valign="middle" >Before</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Min. - Max.</td><td align="center" valign="middle" >0.09 - 2.13</td><td align="center" valign="middle" >0.40 - 1.60</td><td align="center" valign="middle"  rowspan="3"  >0.010</td><td align="center" valign="middle"  rowspan="3"  >0.992</td></tr><tr><td align="center" valign="middle" >Mean &#177; SD.</td><td align="center" valign="middle" >1.08 &#177; 0.38</td><td align="center" valign="middle" >1.08 &#177; 0.40</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >1.04</td><td align="center" valign="middle" >1.16</td></tr><tr><td align="center" valign="middle" >After</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Min. - Max.</td><td align="center" valign="middle" >0.11 - 2.25</td><td align="center" valign="middle" >0.62 - 1.88</td><td align="center" valign="middle"  rowspan="3"  >0.716</td><td align="center" valign="middle"  rowspan="3"  >0.478</td></tr><tr><td align="center" valign="middle" >Mean &#177; SD.</td><td align="center" valign="middle" >1.20 &#177; 0.37</td><td align="center" valign="middle" >1.31 &#177; 0.41</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >1.17</td><td align="center" valign="middle" >1.40</td></tr><tr><td align="center" valign="middle" >p1</td><td align="center" valign="middle" >0.009*</td><td align="center" valign="middle" >0.004*</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >% of change</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="2"  >U = 91.000</td><td align="center" valign="middle"  rowspan="2"  >0.211</td></tr><tr><td align="center" valign="middle" >Mean &#177; SD.</td><td align="center" valign="middle" >15.13 &#177; 21.60</td><td align="center" valign="middle" >26.09 &#177; 18.14</td></tr></tbody></table></table-wrap><p>t, p: t and p values for Student t-test for comparing between the two groups; U, p: U and p values for Mann Whitney test for comparing between the two groups; p1:p value for Paired t-test for comparing between before and after in each group; *: Statistically significant at p ≤ 0.05.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Relation between estimated fetal weight (gm) and cerbro-placental ratio (C/U) before and after MgSO<sub>4</sub> administration</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >C/U ratio</th><th align="center" valign="middle"  colspan="2"  >Estimated fetal weight (gm)</th><th align="center" valign="middle"  rowspan="2"  >T</th><th align="center" valign="middle"  rowspan="2"  >p</th></tr></thead><tr><td align="center" valign="middle" >Normal (n = 28)</td><td align="center" valign="middle" >Oligohydramnios (n = 12)</td></tr><tr><td align="center" valign="middle" >Before</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Min. - Max.</td><td align="center" valign="middle" >0.09 - 2.13</td><td align="center" valign="middle" >0.40 - 1.36</td><td align="center" valign="middle"  rowspan="3"  >1.656</td><td align="center" valign="middle"  rowspan="3"  >0.106</td></tr><tr><td align="center" valign="middle" >Mean &#177; SD.</td><td align="center" valign="middle" >1.14 &#177; 0.40</td><td align="center" valign="middle" >0.93 &#177; 0.27</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >1.14</td><td align="center" valign="middle" >0.91</td></tr><tr><td align="center" valign="middle" >After</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Min. - Max.</td><td align="center" valign="middle" >0.11 - 2.25</td><td align="center" valign="middle" >0.62 - 1.88</td><td align="center" valign="middle"  rowspan="3"  >1.141</td><td align="center" valign="middle"  rowspan="3"  >0.261</td></tr><tr><td align="center" valign="middle" >Mean &#177; SD.</td><td align="center" valign="middle" >1.27 &#177; 0.39</td><td align="center" valign="middle" >1.12 &#177; 0.34</td></tr><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >1.22</td><td align="center" valign="middle" >1.04</td></tr><tr><td align="center" valign="middle" >p1</td><td align="center" valign="middle" >0.013*</td><td align="center" valign="middle" >0.008*</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >% of change</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="2"  >U = 129.000</td><td align="center" valign="middle"  rowspan="2"  >0.250</td></tr><tr><td align="center" valign="middle" >Mean &#177; SD.</td><td align="center" valign="middle" >14.81 &#177; 20.36</td><td align="center" valign="middle" >23.18 &#177; 22.88</td></tr></tbody></table></table-wrap><p>t, p: t and p values for Student t-test for comparing between the two groups; U, p: U and p values for Mann Whitney test for comparing between the two groups; p1:p value for Paired t-test for comparing between before and after in each group; *: Statistically significant at p ≤ 0.05.</p></sec><sec id="s4"><title>4. Discussion</title><p>Preeclampsia is one of the most important serious diseases of pregnancy and occurs in 5% to 7% of pregnant women [<xref ref-type="bibr" rid="scirp.109392-ref34">34</xref>].</p><p>Doppler mood ultrasonic evaluation is used to evaluate blood flow in fetal vessels [<xref ref-type="bibr" rid="scirp.109392-ref35">35</xref>].</p><p>A low index of pulsatility in the MCA associated with fetal decompansation has been described [<xref ref-type="bibr" rid="scirp.109392-ref36">36</xref>].</p><p>Because the cerebroumblical ratio is providing information about placental perfusion and about fetal changes so its an important factor in estimating fetal outcome and well being [<xref ref-type="bibr" rid="scirp.109392-ref37">37</xref>].</p><p>The objective of this study was to assess the effects of administration of MgSO<sub>4</sub> on Doppler parameters of middle cerebral and umbilical arteries in cases of severe PET and eclampsia.</p><p>The study was conducted on 40 pregnant female selected from EL Shatby Maternity University Hospital during the period between December 2015 and December 2016.</p><p>There were 28 cases with normal fetal growth and 12 cases with intrauterine fetal growth restriction. There was statistically significant improve in the C/U ratio after MgSO<sub>4</sub> administration in both of them.</p><p>Regarding the Doppler indices studied in our study, the injection of MgSO<sub>4</sub> could significantly decrease the RI, PI and SD ratio of the umbilical artery, increase the RI, PI and SDR-MCA, thus increase the C/U ratio.</p><p>Souza, et al., [<xref ref-type="bibr" rid="scirp.109392-ref38">38</xref>], assessed MCA and UA Doppler parameters of the fetus. They agree with our study as regard the umbilical artery only but against it as regard the MCA.</p><p>In addition, Souza et al., [<xref ref-type="bibr" rid="scirp.109392-ref38">38</xref>] [<xref ref-type="bibr" rid="scirp.109392-ref39">39</xref>] showed the reduction of PI in the fetal umbilical artery and MCA due to the injection of MgSO<sub>4</sub>.</p><p>Qiao, et al., [<xref ref-type="bibr" rid="scirp.109392-ref40">40</xref>] have found significant changes in parameters after administration of MgSO<sub>4</sub>. In our study, we found significant improvement of C/U ratio after using MgSO<sub>4</sub> treatment with improvement of fetal circulation as it cause umbilical artery vasodilation [<xref ref-type="bibr" rid="scirp.109392-ref41">41</xref>].</p><p>Coleman et al. [<xref ref-type="bibr" rid="scirp.109392-ref42">42</xref>] have found a significant relationship between the resistance index and pregnancy outcomes in 114 pregnant women at 24 - 22 weeks who underwent Doppler sonography. Results of another study have showed a significant relationship between the vascular index and pregnancy outcomes, including fetal growth restriction [<xref ref-type="bibr" rid="scirp.109392-ref43">43</xref>], but results of our study were not in concordance with the last two studies. This difference could be due to the time of Doppler sonography in our study. There was also a control group in order to compare the two groups (treatment and control groups) in terms of resistance index and pregnancy outcomes in these studies, which could produce impressive different results.</p></sec><sec id="s5"><title>5. Conclusions</title><p>● Infusion of MgSO<sub>4</sub> significantly decreases the fetal RI, PI, SDR umbilical and increases the fetal RI, PI, SDR MCA and increases cerebroumblical ratio indices obtained with Doppler ultrasound study.</p><p>● MgSO<sub>4</sub> significantly improves the fetoplacental blood flow.</p><p>● MgSO<sub>4</sub> significantly increases C/U ratio regardless the amount of liquor and the estimated fetal weight were normal or not.</p></sec><sec id="s6"><title>Acknowledgements</title><p>The author is thankful to the Obstetrics and Gynecology Department, Faculty of Medicine, Alexandria University.</p></sec><sec id="s7"><title>Compliance with Ethics Requirements</title><p>All Institutional and National Guidelines for the care and use of animals (insects) were followed.</p></sec><sec id="s8"><title>Author’s Contributions</title><p>DE designed the study and performed data collection and analysis. MR interpreted and supervised the Lab analysis results. NE and NH supervised the clinical examinations and US findings. DE wrote the manuscript. All authors were involved in the revision of the manuscript.</p></sec><sec id="s9"><title>Conflicts of Interest</title><p>The author has declared no conflict of interest.</p></sec><sec id="s10"><title>Cite this paper</title><p>Hefila, N.M. (2021) Magnesium Sulfate Effect on Fetal Umbilical Artery and Middle Cerebral Artery Doppler Indicies in Women with Severe Preeclampsia and Eclampsia. Open Journal of Obstetrics and Gynecology, 11, 636-645. https://doi.org/10.4236/ojog.2021.115059</p></sec></body><back><ref-list><title>References</title><ref id="scirp.109392-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">American College of Obstetricians and Gynecologists [ACOG] (1996) Hypertension in Pregnancy. ACOG Technical Bulletin No. 219. ACOG, Washington DC.</mixed-citation></ref><ref id="scirp.109392-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization [WHO] (1988) Geographic Variation in the Incidence of Hypertension in Pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. American Journal of Obstetrics and Gynecology, 158, 80-83. https://doi.org/10.1016/0002-9378(88)90782-X</mixed-citation></ref><ref id="scirp.109392-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Caritis, S., Sibai, B., Hauth, J., Lindheimer, M.D., Klebanoff, M., Thom, E., et al. (1998) Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. The New England Journal of Medicine, 338, 701-705.  
https://doi.org/10.1056/NEJM199803123381101</mixed-citation></ref><ref id="scirp.109392-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Duckitt, K. and Harrington, D. (2005) Risk Factors for Pre-Eclampsia at Antenatal Booking: Systematic Review of Controlled Studies. BMJ (Clinical Research ed.), 330, 565. https://doi.org/10.1136/bmj.38380.674340.E0</mixed-citation></ref><ref id="scirp.109392-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Esplin, M.S., Fausett, M.B., Fraser, A., Kerber, R., Mineau, G., Carrillo, J., et al. (2001) Paternal and Maternal Components of the Predisposition to Preeclampsia. The New England Journal of Medicine, 344, 867-872.  
https://doi.org/10.1056/NEJM200103223441201</mixed-citation></ref><ref id="scirp.109392-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Roberts, J.M. and Lain, K.Y. (2002) Recent Insights into the Pathogenesis of Pre-Eclampsia. Placenta, 23, 359-372. https://doi.org/10.1053/plac.2002.0819</mixed-citation></ref><ref id="scirp.109392-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Sibai, B., Dekker, G. and Kupferminc, M. (2005) Pre-Eclampsia. The Lancet (London, England), 365, 785-799. https://doi.org/10.1016/S0140-6736(05)17987-2</mixed-citation></ref><ref id="scirp.109392-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Tuffnell, D.J., Jankowicz, D., Lindow, S.W., Lyons, G., Mason, G.C., Russell, I.F., et al. (2005) Outcomes of Severe Pre-Eclampsia/Eclampsia in Yorkshire 1999/2003. BJOG: An International Journal of Obstetrics and Gynaecology, 112, 875-880.  
https://doi.org/10.1111/j.1471-0528.2005.00565.x</mixed-citation></ref><ref id="scirp.109392-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Klungs&amp;oslash;yr, K., Morken, N.H., Irgens, L., Vollset, S.E. and Skjaerven, R. (2012) Secular Trends in the Epidemiology of Pre-Eclampsia throughout 40 Years in Norway: Prevalence, Risk Factors and Perinatal Survival. Paediatric and Perinatal Epidemiology, 26, 190-198. https://doi.org/10.1111/j.1365-3016.2012.01260.x</mixed-citation></ref><ref id="scirp.109392-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Euser, A.G. and Cipolla, M.J. (2009) Magnesium Sulfate for the Treatment of Eclampsia: A Brief Review. Stroke, 40, 1169-1175.  
https://doi.org/10.1161/STROKEAHA.108.527788</mixed-citation></ref><ref id="scirp.109392-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Witlin, A.G. and Sibai, B.M. (1998) Magnesium Sulfate Therapy in Preeclampsia and Eclampsia. Obstetrics and Gynecology, 92, 883-889.  
https://doi.org/10.1097/00006250-199811000-00028</mixed-citation></ref><ref id="scirp.109392-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Euser, A.G., Bullinger, L. and Cipolla, M.J. (2008) Magnesium Sulphate Treatment Decreases Blood-Brain Barrier Permeability during Acute Hypertension in Pregnant Rats. Experimental Physiology, 93, 254-261.  
https://doi.org/10.1113/expphysiol.2007.039966</mixed-citation></ref><ref id="scirp.109392-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Hatab, M.R., Zeeman, G.G. and Twickler, D.M. (2005) The Effect of Magnesium Sulfate on Large Cerebral Artery Blood Flow in Preeclampsia. The Journal of Maternal-Fetal &amp; Neonatal Medicine, 17, 187-192.  
https://doi.org/10.1080/14767050500073050</mixed-citation></ref><ref id="scirp.109392-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Sherman, R., Armory, P., Moody, P., Hope, T. and Mahajan, R.P. (2003) Effects of Magnesium Sulphate on Cerebral Haemodynamics in Healthy Volunteers: A Transcranial Doppler Study. British Journal of Anaesthesia, 91, 273-275.  
https://doi.org/10.1093/bja/aeg170</mixed-citation></ref><ref id="scirp.109392-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Idama, T.O. and Lindow, S.W. (1998) Magnesium Sulphate: A Review of Clinical Pharmacology Applied to Obstetrics. British Journal of Obstetrics and Gynaecology, 105, 260-268. https://doi.org/10.1111/j.1471-0528.1998.tb10084.x</mixed-citation></ref><ref id="scirp.109392-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Altman, D., Carroli, G., Duley, L., Farrell, B., Moodley, J., Neilson, J., et al. (2002) Do Women with Pre-Eclampsia, and Their Babies, Benefit from Magnesium Sulphate? The Magpie Trial: A Randomised Placebo-Controlled Trial. The Lancet (London, England), 359, 1877-1890.  
https://doi.org/10.1016/S0140-6736(02)08778-0</mixed-citation></ref><ref id="scirp.109392-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Reynolds, J.D., Chestnut, D.H., Dexter, F., McGrath, J. and Penning, D.H. (1996) Magnesium Sulfate Adversely Affects Fetal Lamb Survival and Blocks Fetal Cerebral Blood Flow Response during Maternal Hemorrhage. Anesthesia and Analgesia, 83, 493-499. https://doi.org/10.1213/00000539-199609000-00009</mixed-citation></ref><ref id="scirp.109392-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Mihu, D., Diculescu, D., Costin, N., Mihu, C.M., Blaga, L., Ciortea, R., et al. (2011) Applications of Doppler Ultrasound during Labor. Medical Ultrasonography, 13, 141-149.</mixed-citation></ref><ref id="scirp.109392-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Baschat, A.A. and Gembruch, U. (2003) The Cerebroplacental Doppler Ratio Revisited. Ultrasound in Obstetrics &amp; Gynecology, 21, 124-127.  
https://doi.org/10.1002/uog.20</mixed-citation></ref><ref id="scirp.109392-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Divon, M.Y. (1996) Umbilical Artery Doppler Velocimetry: Clinical Utility in High-Risk Pregnancies. American Journal of Obstetrics and Gynecology, 174, 10-14.  
https://doi.org/10.1016/S0002-9378(96)70365-4</mixed-citation></ref><ref id="scirp.109392-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Ebrashy, A., Azmy, O., Ibrahim, M., Waly, M. and Edris, A. (2005) Middle Cerebral/Umbilical Artery Resistance Index Ratio as Sensitive Parameter for Fetal Well-Being and Neonatal Outcome in Patients with Preeclampsia: Case-Control Study. Croatian Medical Journal, 46, 821-825.</mixed-citation></ref><ref id="scirp.109392-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Vyas, S., Nicolaides, K.H., Bower, S. and Campbell, S. (1990) Middle Cerebral Artery Flow Velocity Waveforms in Fetal Hypoxaemia. British Journal of Obstetrics and Gynaecology, 97, 797-803. https://doi.org/10.1111/j.1471-0528.1990.tb02573.x</mixed-citation></ref><ref id="scirp.109392-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Gramellini, D., Folli, M.C., Raboni, S., Vadora, E. and Merialdi, A. (1992) Cerebral-Umbilical Doppler Ratio as a Predictor of Adverse Perinatal Outcome. Obstetrics and Gynecology, 79, 416-420.  
https://doi.org/10.1097/00006250-199203000-00018</mixed-citation></ref><ref id="scirp.109392-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Bahlmann, F., Reinhard, I., Krummenauer, F., Neubert, S., Macchiella, D. and Wellek, S. (2002) Blood Flow Velocity Waveforms of the Fetal Middle Cerebral Artery in a Normal Population: Reference Values from 18 Weeks to 42 Weeks of Gestation. Journal of Perinatal Medicine, 30, 490-501. https://doi.org/10.1515/JPM.2002.077</mixed-citation></ref><ref id="scirp.109392-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Tarzamni, M.K., Nezami, N., Gatreh-Samani, F., Vahedinia, S. and Tarzamni, M. (2009) Doppler Waveform Indices of Fetal Middle Cerebral Artery in Normal 20 to 40 Weeks Pregnancies. Archives of Iranian Medicine, 12, 29-34.</mixed-citation></ref><ref id="scirp.109392-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Yalti, S., Oral, O., Gürbüz, B., Ozden, S. and Atar, F. (2004) Ratio of Middle Cerebral to Umbilical Artery Blood Velocity in Preeclamptic &amp; Hypertensive Women in the Prediction of Poor Perinatal Outcome. The Indian Journal of Medical Research, 120, 44-50.</mixed-citation></ref><ref id="scirp.109392-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Rana, M., Amanullah, A. and Farooq, O. (2005) The Role of Umblical Artery Doppler in Detection and Management of Fetal Growth Retardation. Biomedica, 21, 4-7.</mixed-citation></ref><ref id="scirp.109392-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Kassanos, D., Siristatidis, C., Vitoratos, N., Salamalekis, E. and Creatsas, G. (2003) The Clinical Significance of Doppler Findings in Fetal Middle Cerebral Artery during Labor. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 109, 45-50. https://doi.org/10.1016/S0301-2115(02)00512-2</mixed-citation></ref><ref id="scirp.109392-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Keeley, M.M., Wade, R.V., Laurent, S.L. and Hamann, V.D. (1993) Alterations in Maternal-Fetal Doppler Flow Velocity Waveforms in Preterm Labor Patients Undergoing Magnesium Sulfate Tocolysis. Obstetrics and Gynecology, 81, 191-194.</mixed-citation></ref><ref id="scirp.109392-ref30"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schroeder</surname><given-names> B.M. </given-names></name>,<etal>et al</etal>. (<year>2002</year>)<article-title>ACOG Practice Bulletin on Diagnosing and Managing Preeclampsia and Eclampsia. American College of Obstetricians and Gynecologists</article-title><source> American Family Physician</source><volume> 66</volume>,<fpage> 330</fpage>-<lpage>331</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.109392-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Sibai, B.M., Caritis, S. and Hauth, J. (2003) What We Have Learned about Preeclampsia. Seminars in Perinatology, 27, 239-246.  
https://doi.org/10.1016/S0146-0005(03)00022-3</mixed-citation></ref><ref id="scirp.109392-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">ACOG Committee on Practice Bulletins—Obstetrics (2002) ACOG Practice Bulletin. Diagnosis and Management of Preeclampsia and Eclampsia. Number 33, January 2002. Obstetrics and Gynecology, 99, 159-167.  
https://doi.org/10.1097/00006250-200201000-00028</mixed-citation></ref><ref id="scirp.109392-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Lindheimer, M.D., Taler, S.J. and Cunningham, F.G. (2008) Hypertension in Pregnancy. Journal of the American Society of Hypertension: JASH, 2, 484-494.  
https://doi.org/10.1016/j.jash.2008.10.001</mixed-citation></ref><ref id="scirp.109392-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Lindheimer, M.D., Taler, S.J. and Cunningham, F.G. (2009) ASH Position Paper: Hypertension in Pregnancy. Journal of Clinical Hypertension (Greenwich, Conn.), 11, 214-225. https://doi.org/10.1111/j.1751-7176.2009.00085.x</mixed-citation></ref><ref id="scirp.109392-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Neilson, J.P. and Alfirevic, Z. (2000) Doppler Ultrasound for Fetal Assessment in High Risk Pregnancies. The Cochrane Database of Systematic Reviews, No. 2, Cd000073.</mixed-citation></ref><ref id="scirp.109392-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Madazli, R., Uludag, S. and Ocak, V. (2001) Doppler Assessment of Umbilical Artery, Thoracic Aorta and Middle Cerebral Artery in the Management of Pregnancies with Growth Restriction. Acta Obstetricia et Gynecologica Scandinavica, 80, 702-707. https://doi.org/10.1034/j.1600-0412.2001.080008702.x</mixed-citation></ref><ref id="scirp.109392-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Bahado-Singh, R.O., Kovanci, E., Jeffres, A., Oz, U., Deren, O., Copel, J., et al. (1999) The Doppler Cerebroplacental Ratio and Perinatal Outcome in Intrauterine Growth Restriction. American Journal of Obstetrics and Gynecology, 180, 750-756.  
https://doi.org/10.1016/S0002-9378(99)70283-8</mixed-citation></ref><ref id="scirp.109392-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Souza, A.S., Amorim, M.M., Coêlho, I.C., Lima, M.M., Noronha Neto, C. and Figueroa, J.N. (2008) Doppler of the Umbilical and Fetal Middle Cerebral Arteries after Magnesium Sulfate in Preeclampsia. Revista da Associacao Medica Brasileira (1992), 54, 232-237. https://doi.org/10.1590/S0104-42302008000300016</mixed-citation></ref><ref id="scirp.109392-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Souza, A.S., Amorim, M.M., Coutinho, I.C., Lima, M.M., Noronha Neto, C. and Figueroa, J.N. (2010) Effect of the Loading Dose of Magnesium Sulfate (MgSO4) on the Parameters of Doppler Flow Velocity in the Uterine, Umbilical and Middle Cerebral Arteries in Severe Preeclampsia. Hypertension in Pregnancy, 29, 123-134.  
https://doi.org/10.3109/10641950902875772</mixed-citation></ref><ref id="scirp.109392-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Qiao, F., Wen, L. and Xu, J. (1995) Uteroplacental Blood Flow Monitoring by Color Doppler Flow Imaging in Pregnancy Induced Hypertension. Chinese Journal of Obstetrics and Gynecology, 30, 337-339.</mixed-citation></ref><ref id="scirp.109392-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Makhseed, M., Jirous, J., Ahmed, M.A. and Viswanathan, D.L. (2000) Middle Cerebral Artery to Umbilical Artery Resistance Index Ratio in the Prediction of Neonatal Outcome. International Journal of Gynaecology and Obstetrics, 71, 119-125.  
https://doi.org/10.1016/S0020-7292(00)00262-9</mixed-citation></ref><ref id="scirp.109392-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Coleman, M.A., McCowan, L.M. and North, R.A. (2000) Mid-Trimester Uterine Artery Doppler Screening as a Predictor of Adverse Pregnancy Outcome in High-Risk Women. Ultrasound in Obstetrics &amp; Gynecology, 15, 7-12.  
https://doi.org/10.1046/j.1469-0705.2000.00014.x</mixed-citation></ref><ref id="scirp.109392-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Aardema, M.W., Oosterhof, H., Timmer, A., van Rooy, I. and Aarnoudse, J.G. (2001) Uterine Artery Doppler Flow and Uteroplacental Vascular Pathology in Normal Pregnancies and Pregnancies Complicated by Pre-Eclampsia and Small for Gestational Age Fetuses. Placenta, 22, 405-411.  
https://doi.org/10.1053/plac.2001.0676</mixed-citation></ref></ref-list></back></article>